Influence of Key Clinical Baseline Characteristics on Benralizumab Response for Patients with Severe, Uncontrolled Asthma and Moderate Blood Eosinophilia

Subjects

Subjects :

medicine.medical_specialty
business.industry
Immunology
Benralizumab
Uncontrolled asthma
chemistry.chemical_compound
chemistry
Baseline characteristics
Internal medicine
medicine
Immunology and Allergy
Eosinophilia
medicine.symptom
business

Details

ISSN :

00916749

Volume :

145

Database :

OpenAIRE

Journal :

Journal of Allergy and Clinical Immunology

Accession number :

edsair.doi...........76892d7d608967b3c2ec6d521022ea34

Full Text :

https://doi.org/10.1016/j.jaci.2019.12.797